Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.

ABSTRACT:

SUBMITTER: Mack PC

PROVIDER: S-EPMC9020481 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.

Mack Philip C PC Gomez Jorge E JE Rodilla Ananda M AM Carreño Juan Manuel JM Hsu Chih-Yuan CY Rolfo Christian C Meshulami Noy N Moore Amy A Brody Rachel I RI King Jennifer C JC Treatman Jacquelyn J Lee Sooyun S Raskin Ariel A Srivastava Komal K Gleason Charles R CR de Miguel-Perez Diego D Tcheou Johnstone J Bielak Dominika D Acharya Rashmi R Gerber David E DE Rohs Nicholas N Henschke Claudia I CI Yankelevitz David F DF Simon Viviana V Minna John D JD Bunn Paul A PA García-Sastre Adolfo A Krammer Florian F Shyr Yu Y Hirsch Fred R FR

Cancer cell 20220420 6

PMID: 35504289

Similar Datasets

Pre-existing cross-reactive antibody responses do not significantly impact inactivated COVID-19 vaccine-induced neutralization

Project description:Recent exposure to seasonal coronaviruses (sCoVs) may stimulate cross-reactive antibody responses against SARS-CoV-2. Previous studies have shown divergent results regarding protective or damaging immunity induced by prior exposure to sCoVs. It is still unknown whether pre-existing humoral immunity may play a role in the vaccine-induced neutralization and antibody responses. In this study, we collected 36 paired sera in healthy volunteers before and after immunization with inactivated SARS-CoV-2 vaccines, and analyzed the distribution and intensity of pre-existing antibody responses at the epitope level before vaccine immunization, as well as the relationship between pre-existing sCoVs immunity and vaccine-induced neutralization.

2021-10-13 | E-MTAB-11084 | biostudies-arrayexpress

Pre-existing cross-reactive antibody responses do not significantly impact inactivated COVID-19 vaccine-induced neutralization

2021-10-29 | E-MTAB-11117 | biostudies-arrayexpress

Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination.

Project description: Not available

| S-EPMC8504644 | biostudies-literature

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron.

Project description: Not available

| S-EPMC8949546 | biostudies-literature

mRNA vaccination in octogenarian nuns 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron

Project description:Knowledge about the impact of prior SARS-CoV-2 infection of the elderly on mRNA vaccination response is needed to appropriately address the demand for additional vaccinations in this vulnerable population. Here we show that octogenarians, a high-risk population, mount a sustained SARS-CoV-2 spike-specific IgG antibody response for 15 months following infection. This response boosts antibody levels 35-fold upon receiving a single dose of BNT162b2 mRNA vaccine 15 months after recovery from COVID-19. In contrast, antibody responses in naïve individuals boost only 6-fold after a second vaccine. Spike-specific ACE2 antibody binding responses in the previously infected octogenarians following two vaccine doses exceed those found in a naïve cohort after two doses. RNA-seq demonstrates activation of interferon-induced genetic programs, which persist only in the previously infected. A preferential increase of specific IGHV clonal transcripts that are the basis of neutralizing antibodies is observed only in the previously infected nuns.

2022-03-09 | GSE190747 | GEO

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization.

Project description: Not available

| S-EPMC8640209 | biostudies-literature

Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatment.

Project description: Not available

| S-EPMC9750888 | biostudies-literature

Longitudinal proteomic investigation of COVID-19 vaccination

Project description:163 participants with paired peripheral blood mononuclear cells and serum samples，at D0, D28, day 57 (D57) by TMT-based proteomics

2023-09-06 | PXD039826 |

Population antibody responses following COVID-19 vaccination in 212,102 individuals.

Project description: Not available

| S-EPMC8850615 | biostudies-literature

Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.

Project description: Not available

| S-EPMC9214150 | biostudies-literature